Industry

BRISTOL, N.J. & SEOUL–(BUSINESS WIRE)–Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today announced that it has entered into an agreement with Seoul-based MDimune Inc. to apply their nanovesicle technology to enhance the effects of chimeric antigen receptor-expressing natural killer (CAR-NK) cells on various solid … [Read more…]

Ten EVS technicians will each receive $2,500 through Cintas’ third-annual EVS award program CINCINNATI–(BUSINESS WIRE)–In honor of Environmental Services (EVS) week, which is being recognized September 11-17, Cintas Corporation (Nasdaq: CTAS) is proud to announce the winners of its 2022 C.A.P.E. Awards. These awards were established to recognize professionals “Cleaning to Advance the Patient Experience.” … [Read more…]

10th annual MedAxiom cardiovascular provider compensation and production report reveals year-over-year comparisons and decade trends NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 10th annual Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a … [Read more…]

EARTH CITY, Mo.–(BUSINESS WIRE)–Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces its support of the inaugural Gene Therapy and Specialty Pharmacy Awareness month, September 2022. The observance is included in the annual Calendar of Health Observances & Recognition Days, … [Read more…]

The addition of Daylight for anxiety and Sleepio for insomnia expands access to evidence-based digital cognitive behavioral therapy to thousands of Americans SAN FRANCISCO–(BUSINESS WIRE)–Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced that Daylight for anxiety and Sleepio for insomnia have been added to the Evernorth … [Read more…]

Zerigo Health’s latest software release includes integrated, guideline-recommended phototherapy dosing protocols for the treatment of atopic dermatitis (commonly referred to as eczema), in addition to its existing protocols for psoriasis Evernorth, Cigna’s health services business, will offer Zerigo’s solution as part of a pilot program through its Digital Health Formulary and is the first to … [Read more…]

Applies violeds technology developed by Seoul Viosys, the world’s number one UV LED company Removes up to 99.9% of harmful germs (E.coli, staphylococcus aureus, and pneumococci) within 10 minutes with UVC Seoul Viosys offers optimized disinfection solutions, operating its own auto lab. ANSAN, South Korea–(BUSINESS WIRE)–#GenesisG90–UV-C disinfection technology solution, Violeds, developed by Seoul Semiconductor Co., … [Read more…]

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Drug (RPD) designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in muscle, for the treatment of Pompe disease. Pompe disease is a rare and deadly … [Read more…]

The company’s latest product design innovation makes the product fit and feel like regular underwear RALEIGH, N.C.–(BUSINESS WIRE)–#attindas–Attindas Hygiene Partners is proud to announce its innovative new adult disposable incontinence underwear product in North America. Invisible under clothing while providing up to 100% leak-free protection, the new product leverages Maxi Comfort ultrasonic bonding technology for … [Read more…]

Dr. Thomas, Founder and CEO of Metagenomi, will help company advance its pipeline of RNA-guided programmable precision medicines LAUSANNE, Switzerland and SAN DIEGO–(BUSINESS WIRE)–#RNA—HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Brian C. Thomas, Ph.D., has joined HAYA as Chairperson of the Board of … [Read more…]